Jerusalem Pharmaceuticals Co. Ltd. (PEX: JPH)

Jerusalem Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.07	6.59	7.73	5.44	1.96	1.15
Short-Term Investments	0.01	0.05	0.03	0.03	0.04	0.03
Trading Asset Securities	2.6	2.12	0.03	0.03	0.02	0.02
Cash & Short-Term Investments	8.68	8.76	7.79	5.49	2.02	1.21
Cash Growth	-34.42%	12.53%	41.69%	171.63%	67.77%	-52.83%
Accounts Receivable	26.5	29.95	31.63	30.81	24.2	19.93
Other Receivables	0.03	-	-	-	0.72	0.86
Receivables	26.53	29.95	31.63	30.81	24.92	20.79
Inventory	10.37	10.41	10.88	14.76	14.44	14.52
Prepaid Expenses	0.51	0.51	0.4	0.73	0.73	0.07
Other Current Assets	3.91	3.1	2.22	3.33	3.2	3.17
Total Current Assets	50	52.73	52.91	55.12	45.3	39.76
Property, Plant & Equipment	26.9	27.13	25.48	27.47	27.15	25.41
Long-Term Investments	4.6	4.3	3.22	0.7	1.22	1.48
Other Intangible Assets	1.46	1.55	1.52	3.04	3.53	3.64
Long-Term Deferred Tax Assets	0.36	0.28	0.27	0.2	0.16	0.15
Other Long-Term Assets	0.46	0.32	0.32	0.37	0.36	0.33
Total Assets	84.13	86.32	83.72	86.89	77.71	70.76
Accounts Payable	4.88	3.48	6.56	5.11	4.35	4.62
Accrued Expenses	2.21	2.33	1.32	1.99	1.39	1.2
Short-Term Debt	-	0.52	0.65	0.78	1.69	2.46
Current Portion of Long-Term Debt	1.5	1.13	0.69	0.57	0.6	0.47
Current Portion of Leases	0.38	0.48	0.36	0.55	0.64	0.46
Current Income Taxes Payable	1.26	2.42	2.67	1.66	0.18	0.16
Other Current Liabilities	3.78	1.95	1.46	2.3	2	1.82
Total Current Liabilities	14.01	12.32	13.7	12.97	10.84	11.19
Long-Term Debt	-	-	-	-	0.38	-
Long-Term Leases	0.13	0.33	0.49	0.72	0.55	0.95
Total Liabilities	18.88	17.44	18.49	18.32	16.07	16.03
Common Stock	18	18	18	18	18	18
Additional Paid-In Capital	3.72	3.72	3.72	3.72	3.72	3.72
Retained Earnings	39.02	39.6	34.9	29.89	24.73	22.8
Comprehensive Income & Other	3.54	6.52	7.65	14.87	12.87	7.72
Total Common Equity	64.28	67.84	64.27	66.47	59.32	52.24
Minority Interest	0.96	1.04	0.96	2.1	2.32	2.49
Shareholders' Equity	65.24	68.88	65.23	68.57	61.64	54.73
Total Liabilities & Equity	84.13	86.32	83.72	86.89	77.71	70.76
Total Debt	2.01	2.47	2.18	2.63	3.85	4.33
Net Cash (Debt)	6.67	6.29	5.6	2.86	-1.83	-3.12
Net Cash Growth	-31.16%	12.22%	95.69%	-	-	-
Net Cash Per Share	0.37	0.35	0.31	0.16	-0.10	-0.17
Filing Date Shares Outstanding	18	18	18	18	18	18
Total Common Shares Outstanding	18	18	18	18	18	18
Working Capital	35.99	40.4	39.2	42.16	34.46	28.57
Book Value Per Share	3.57	3.77	3.57	3.69	3.30	2.90
Tangible Book Value	62.82	66.29	62.75	63.43	55.8	48.6
Tangible Book Value Per Share	3.49	3.68	3.49	3.52	3.10	2.70
Land	10.17	-	9.24	8.31	8.13	7.55
Buildings	15.03	-	15.73	16.34	15.87	14.72
Machinery	28.8	-	28.78	31.82	29.69	26.07

Source: S&P Capital IQ. Standard template. Financial Sources.